Asana, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Asana, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	76.8	143	227	378	547	653	724	791
Cost of revenue	13.8	19.9	28.7	38.9	56.6	64.5	77.2	86.8
Gross profit	62.9	123	198	340	491	588	647	704
Research and development	42.6	89.7	121	203	297	325	341	301
Selling and marketing	52.1	106	176	283	435	392	420	407
General and administrative	20.3	46.8	76.2	119	166	141	152	193
Operating expenses	115	242	374	605	898	858	913	901
Operating income	-52	-120	-176	-265	-408	-270	-267	-197
Interest expense	0	0.08	36.2	18.4	2	3.95	3.68	3.15
Other non-operating income		1.37	1.57	-1.54	6.93	20.6	19.6	16.3
Pre-tax income	-50.9	-118	-210	-285	-403	-253	-251	-184
Income tax	0.03	0.25	1.53	3.24	4.88	3.71	4.77	4.86
Net income	-50.9	-119	-212	-288	-408	-257	-256	-189
EBITDA	-47.8	-117	-172	-257	-395	-256	-249	-175
EPS, basic	-0.78	-1.69	-1.99	-1.63	-2.04	-1.17	-1.11	-0.80
EPS, diluted	-0.78	-1.69	-1.99	-1.63	-2.04	-1.17	-1.11	-0.80
Shares, basic (weighted)	65.2	70.3	106	176	200	220	229	237
Shares, diluted (weighted)	65.2	70.3	106	176	200	220	229	237

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	23.8	306	260	240	527	237	185	200
Short-term investments		45.3	126	71.6	2.74
Receivables		12.7	32.2	59.1	82.4	88.3	87.6	110
Other current assets		3.5	4.86	6.51	5.54	5.3	6.3	9.22
Total current assets		381	446	411	660	660	601	593
Property, plant and equipment		10.1	74.4	99.6	95	96.5	95.8	88.3
Lease right-of-use assets		20.8	183	174	176	182	167	133
Goodwill								0
Intangible assets								0
Long-term investments		0	19.1	2.76	0
Other non-current assets		5.48	8.87	19.2	23.4	24	28.3	29
Total assets		422	731	707	955	962	891	844
Accounts payable		7.55	9.6	11.6	7.55	6.91	9.92	18.8
Accrued liabilities		3.48	10.6	16.9	22.3	19.2	22.6	24.1
Deferred revenue		62.7	104	170	226	265	301	334
Short-term debt							0	40.8
Total current liabilities		100	163	255	332	367	416	501
Lease liabilities		10.5	197	208	210	215	202	184
Other non-current liabilities		2.73	2.96	0.89	2.21	3.73	5.05	4.98
Total liabilities		316	744	503	598	636	664	690
Total debt							0	40.8
Paid-in capital		185	529	1,034	1,595	1,821	2,060	2,300
Retained earnings		-330	-541	-830	-1,238	-1,495	-1,828	-2,150
Other comprehensive income		-0.1	0.04	-0.63	-0.87	-0.24	-3.85	4.21
Shareholders' equity	-181	-145	-12.8	204	357	326	228	154
Total equity	-181	-145	-12.8	204	357	326	228	154
Total liabilities and equity		422	731	707	955	962	891	844
Shares outstanding			161	188	214	225

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-50.9	-119	-212	-288	-408	-257	-256	-189
Depreciation and amortization	4.2	2.2	3.5	8.5	12.7	14.3	17.5	22
Stock-based compensation	8.55	48.4	34.2	105	189	202	211	215
Deferred income tax	0	0	0.23	0.21	0.82	0.15	0.35	0.41
Change in receivables	-3.43	-7.72	-20.5	-27	-25.2	-9.53	-4.66	-23.5
Change in payables	0.36	3.47	-2.88	7.26	-4.39	-0.57	4.44	7.32
Cash from operations	-30.2	-40.1	-92.9	-83.8	-160	-17.9	14.9	90.4
Capital expenditures	-2.85	-6.88	-57.3	-41.6	-5.35	-7.72	-5.57	-3.79
Purchases of investments	-103	-77.8	-192	-62.4	-72.2	-319	-234	-179
Sales and maturities of investments	62	93.4	53.8	132	144	43.1	241	206
Cash from investing	-44.7	12.7	-159	27.6	64.5	-289	-6.13	37.2
Debt issued	0	0	30.9	9	49.6	0	0
Debt repaid		0	0	-1.67	-38.3	-3.13	-2.5	-3.75
Stock issued	4.3	11.7	20.5	16.6	5.77	4.84	9.1	5.02
Share buybacks	-0.01	-0.08	-0.03	-0.04	-0.01	0	-78.4	-132
Cash from financing	55.3	312	201	37.2	381	16.8	-58.1	-118
Exchange rate effect	0	-0.02	0	-0.46	0.34	0.39	-2.5	5.79
Net change in cash	-19.5	284	-50.8	-19.5	286	-290	-51.8	15.4
Free cash flow	-33	-47	-150	-125	-165	-25.7	9.36	86.6
Interest paid		0	0.08	0.83	1.66	3.61	5.94	2.88
Income taxes paid		0.15	0.28	1.46	4.33	3.35	4.25	5.03

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $9.02 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	87.6%	Gross profit / revenue.
Operating margin	-19.4%	Operating income / revenue.
EBITDA margin	-16.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-18.3%	Pre-tax income / revenue.
Net margin	-18.6%	Net income / revenue.
FCF margin	15.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.7%	Cash from operations / revenue.
Return on equity (ROE)	-147.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-18.9%	Net income / average total assets.
R&D / revenue	35.6%	Research and development expense / revenue.
Stock-based pay / revenue	23.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	13.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	28.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	28.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	505.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	825.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-32.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-24.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-5.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	17.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.92x	Current assets / current liabilities.
Quick ratio	0.58x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.43x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.36x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	4.5%	Total debt / total assets.
Liabilities / assets	87.2%	Total liabilities / total assets.
Net debt	-$182.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-56.2x	Operating income / interest expense.
Working capital	-$41.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	9.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$30.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.01x	Revenue / average total assets.
Fixed asset turnover	9.10x	Revenue / average property, plant and equipment.
Receivables turnover	10.5x	Revenue / average receivables.
Days sales outstanding	35 days	365 x average receivables / revenue.
Days payables	55 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	4.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.67	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$3.59	Revenue / diluted weighted shares.
FCF per share	$0.54	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.56	Cash from operations / diluted weighted shares.
Book value per share	$0.45	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.13	Tangible book value / shares outstanding.
Cash per share	$0.95	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	149.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.08B	Share price x shares outstanding.
Enterprise value	$1.90B	Market cap + total debt - cash - short-term investments.
P/S	2.51x	Market cap / revenue.
P/B	19.9x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	69.3x	Market cap / tangible book value, when positive.
P/FCF	16.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	16.0x	Market cap / cash from operations, when positive.
EV/Sales	2.29x	Enterprise value / revenue.
EV/FCF	15.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.0%	Free cash flow / market cap.
Earnings yield	-7.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	8.9%	(Dividends paid + share buybacks) / market cap.

What was Asana, Inc.'s revenue in fiscal 2026?

Asana, Inc. reported revenue of $790.8M for fiscal 2026, 9.2% higher than the year before.

Was Asana, Inc. profitable in fiscal 2026?

No. It reported a net loss of $189.0M.

How much free cash flow did Asana, Inc. generate in fiscal 2026?

Cash from operations of $90.4M minus capital expenditures of $3.8M left free cash flow of $86.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Asana, Inc.